Ensayos clínicos A menudo, Mayo Clinic realiza estudios clínicos sobre diversos temas relacionados con la atención médica general y en varios estados, como en Minnesota, Florida y Arizona. A continuación se enumeran ensayos clínicos actuales.15 estudios en Medicina interna general (estudios abiertos únicamente). Filtrar esta lista de estudios según la ubicación, el estado del estudio y más. Undiagnosed Tumor/Undifferentiated Mass Registry Rochester, Minn., Scottsdale/Phoenix, Ariz., Jacksonville, Fla. The purpose of this study is to create a research registry to prospectively collect research biospecimens and corresponding clinical data from subjects with an undiagnosed tumor or undifferentiated mass. GENetic Risk Estimation of Breast Cancer Prior to Decisions on Preventive Therapy Uptake, Risk Reducing Surgery or Intensive Imaging Surveillance Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment Tool (BCRAT) or Tyrer-Cuzick (IBIS) score will aid women at risk of breast cancer in making a decision to take (or not take) medications to prevent breast cancer. Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS Rochester, Minn., Scottsdale/Phoenix, Ariz. The primary objective of the trial is to evaluate the long-term safety of glepaglutide treatment in patients with short bowel syndrome (SBS). Glepaglutide is the International Nonproprietary Name and USAN for ZP1848. Cellular Senescence and COVID-19 Long-Hauler Syndrome Rochester, Minn. The purpose of this study is to test if senescent cells and their secretome contribute to Long-Hauler Syndrome and if a clinical trial of senolytic drugs, which selectively eliminate senescent cells, should be initiated. Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Women Rochester, Minn. This is a pilot study to evaluate whether targeting inflammation will help reduce markers of insulin resistance inflammation, bone resorption and physical dysfunction in elderly women with gait disturbance. Positive results of this study would lead to the development of a larger clinical trial examining the effects of this intervention on age-related dysfunction. Numeración de páginas Estudios clínicos AnteriorPágina anterior Ir a página 11 Ir a página 22 A continuación se enumeran ensayos clínicos actuales.15 estudios en Medicina interna general (estudios abiertos únicamente). Filtrar esta lista de estudios según la ubicación, el estado del estudio y más. Undiagnosed Tumor/Undifferentiated Mass Registry Rochester, Minn., Scottsdale/Phoenix, Ariz., Jacksonville, Fla. The purpose of this study is to create a research registry to prospectively collect research biospecimens and corresponding clinical data from subjects with an undiagnosed tumor or undifferentiated mass. GENetic Risk Estimation of Breast Cancer Prior to Decisions on Preventive Therapy Uptake, Risk Reducing Surgery or Intensive Imaging Surveillance Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment Tool (BCRAT) or Tyrer-Cuzick (IBIS) score will aid women at risk of breast cancer in making a decision to take (or not take) medications to prevent breast cancer. Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS Rochester, Minn., Scottsdale/Phoenix, Ariz. The primary objective of the trial is to evaluate the long-term safety of glepaglutide treatment in patients with short bowel syndrome (SBS). Glepaglutide is the International Nonproprietary Name and USAN for ZP1848. Cellular Senescence and COVID-19 Long-Hauler Syndrome Rochester, Minn. The purpose of this study is to test if senescent cells and their secretome contribute to Long-Hauler Syndrome and if a clinical trial of senolytic drugs, which selectively eliminate senescent cells, should be initiated. Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Women Rochester, Minn. This is a pilot study to evaluate whether targeting inflammation will help reduce markers of insulin resistance inflammation, bone resorption and physical dysfunction in elderly women with gait disturbance. Positive results of this study would lead to the development of a larger clinical trial examining the effects of this intervention on age-related dysfunction. Numeración de páginas Estudios clínicos AnteriorPágina anterior Ir a página 11 Ir a página 22 Solicite una consulta Grupos especializadosInvestigación April 25, 2024 Comparte en: FacebookTwitter Medicina interna generalSeccionesPanorama generalMédicosGrupos especializadosEnsayos clínicosInvestigaciónCostos & seguro médicoRemisiones Investigación: los pacientes son la prioridad Mostrar la transcripción Para video Investigación: los pacientes son la prioridad [SUENA MÚSICA] Dr. Joseph Sirven, profesor de Neurología, Mayo Clinic: La misión de Mayo se centra en el paciente. La prioridad es el paciente. Aquí, la misión y la investigación se hacen para progresar en la forma de ayudar mejor al paciente y para asegurarnos de que el paciente sea la prioridad en la atención médica. De muchas maneras, esto equivale a un ciclo. Puede comenzar con algo tan simple como una idea que se desarrolla en un laboratorio, se traslada a la atención directa del paciente y, si todo sale bien y resulta útil o beneficioso, pasa a ser el método estándar. Creo que una de las características tan singulares de la forma de investigar en Mayo es la concentración en el paciente, y es lo que realmente le ayuda a captar la atención de todos. SeccionesSolicite una ConsultaPanorama generalMédicosGrupos especializadosEnsayos clínicosInvestigaciónCostos & seguro médicoRemisiones ORG-20461600 Centros y departamentos médicos Medicina interna general